Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05868330 · ClinicalTrials.gov registry record · Phase 4

Comparison of Interscalene Catheter to Single Injection Interscalene Blocks for Total Shoulder Arthroplasties

A Phase 4 study of Anesthesia and Post Operative Pain, sponsored by Melinda Seering.

Recruiting
Registry status
Phase 4
Development phase
56
Enrollment target
1
Study location

NCT05868330 is a Phase 4 study of Anesthesia and Post Operative Pain that is actively recruiting participants, run by Melinda Seering. The registered enrollment target is 56 participants, below the 109,409-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05868330, a Phase 4 study of Anesthesia and Post Operative Pain, is actively recruiting participants, sponsored by Melinda Seering.

RECRUITING
Registry status
Phase 4
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

Comparison of post-operative pain after total shoulder surgery. The Principle Investigator will be comparing Exparel single shot block to Interscalene catheter

Interventions

  • PROCEDURE Interscalene Catheter
  • PROCEDURE Exparel Single Shot Interscalene Block

Study Locations (1)

Iowa

  • University of Iowa Hospital and Clinics - Iowa City

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2024-08-19
Est. Completion 2027-01
Phase Phase 4

Sponsor

Melinda Seering

3 total trials

What the Registry Record Tells You About NCT05868330

The ClinicalTrials.gov registry entry for NCT05868330 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 109,409-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The listed sponsor is Melinda Seering, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Anesthesia appearing as the primary indexed condition, and to 2 interventions - of which Interscalene Catheter is the first listed.

NCT05868330 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.

Frequently Asked Questions

What is clinical trial NCT05868330 about?

NCT05868330 is a clinical study titled "Comparison of Interscalene Catheter to Single Injection Interscalene Blocks for Total Shoulder Arthroplasties". Comparison of post-operative pain after total shoulder surgery. The Principle Investigator will be comparing Exparel single shot block to Interscalene catheter

What is the current status of trial NCT05868330?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 56 participants. The study started on 2024-08-19. Estimated completion is 2027-01.

What conditions does trial NCT05868330 study?

This clinical trial studies the following conditions: Anesthesia, Post Operative Pain, Shoulder Osteoarthritis, Nerve Block.

What interventions are being tested in trial NCT05868330?

The interventions under investigation include: Interscalene Catheter (PROCEDURE), Exparel Single Shot Interscalene Block (PROCEDURE).

Who is sponsoring clinical trial NCT05868330?

This trial is sponsored by Melinda Seering, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05868330 being conducted?

This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anesthesia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.